TY - JOUR
T1 - Ginger supplement significantly reduced length of hospital stay in individuals with COVID-19
AU - Li, Yaqi
AU - Yang, Dawei
AU - Gao, Xiwen
AU - Ju, Minjie
AU - Fang, Hao
AU - Yan, Zuoqin
AU - Qu, Huanru
AU - Zhang, Yuanhao
AU - Xie, Linshan
AU - Weng, Huifen
AU - Bai, Chunxue
AU - Song, Yuanlin
AU - Sun, Zhirong
AU - Geng, Wenye
AU - Gao, Xiang
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: Evidence from previous studies has suggested that ginger extract exhibits the potential as an alternative treatment for Coronavirus disease 2019 (COVID-19). Here, we want to investigate whether ginger supplement improves the clinical manifestation of hospitalized COVID-19 individuals. Methods: A total of 227 hospitalized individuals with COVID-19 were randomized to either the control (n = 132) or intervention group (n = 95). The intervention group took ginger supplement orally at the dosage of 1.5 g twice daily, until they were discharged from the hospital. Both groups received the same standard of general medical care during hospitalization, and the length of stay was recorded and compared between groups. Results: Among all participants, a significant reduction in hospitalization time (the difference between the treatment and control groups was 2.4 d, 95% CI 1.6–3.2) was detected in response to the ginger supplement. This effect was more pronounced in men, participants aged 60 years or older, and participants with pre-existing medical conditions, relative to their counterparts (P-interactions < 0.05 for all). Conclusion: Ginger supplement significantly shortened the length of stay of hospitalized individuals with COVID-19. Trial registration: The trial was registered on the Chinese Clinical Trial Registry (ChiCTR2200059824).
AB - Background: Evidence from previous studies has suggested that ginger extract exhibits the potential as an alternative treatment for Coronavirus disease 2019 (COVID-19). Here, we want to investigate whether ginger supplement improves the clinical manifestation of hospitalized COVID-19 individuals. Methods: A total of 227 hospitalized individuals with COVID-19 were randomized to either the control (n = 132) or intervention group (n = 95). The intervention group took ginger supplement orally at the dosage of 1.5 g twice daily, until they were discharged from the hospital. Both groups received the same standard of general medical care during hospitalization, and the length of stay was recorded and compared between groups. Results: Among all participants, a significant reduction in hospitalization time (the difference between the treatment and control groups was 2.4 d, 95% CI 1.6–3.2) was detected in response to the ginger supplement. This effect was more pronounced in men, participants aged 60 years or older, and participants with pre-existing medical conditions, relative to their counterparts (P-interactions < 0.05 for all). Conclusion: Ginger supplement significantly shortened the length of stay of hospitalized individuals with COVID-19. Trial registration: The trial was registered on the Chinese Clinical Trial Registry (ChiCTR2200059824).
UR - http://www.scopus.com/inward/record.url?scp=85145217842&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85145217842&partnerID=8YFLogxK
U2 - 10.1186/s12986-022-00717-w
DO - 10.1186/s12986-022-00717-w
M3 - Article
C2 - 36578045
AN - SCOPUS:85145217842
SN - 1743-7075
VL - 19
JO - Nutrition and Metabolism
JF - Nutrition and Metabolism
IS - 1
M1 - 84
ER -